148 related articles for article (PubMed ID: 26453118)
1. Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer.
Li H; Zhao T; Ji X; Liang S; Wang Z; Yang Y; Yin J; Wang R
Tumour Biol; 2016 Mar; 37(3):3535-42. PubMed ID: 26453118
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer.
McNamara MG; Templeton AJ; Maganti M; Walter T; Horgan AM; McKeever L; Min T; Amir E; Knox JJ
Eur J Cancer; 2014 Jun; 50(9):1581-9. PubMed ID: 24630393
[TBL] [Abstract][Full Text] [Related]
3. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.
Feng Z; Wen H; Bi R; Duan Y; Yang W; Wu X
BMC Cancer; 2016 Jan; 16():43. PubMed ID: 26817451
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of preoperative plasma fibrinogen level and platelet count in resectable esophageal squamous cell carcinoma.
Wang J; Liu H; Shao N; Tan B; Song Q; Jia Y; Cheng Y
World J Surg Oncol; 2015 Apr; 13():157. PubMed ID: 25896470
[TBL] [Abstract][Full Text] [Related]
5. Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer.
Son HJ; Park JW; Chang HJ; Kim DY; Kim BC; Kim SY; Park SC; Choi HS; Oh JH
Ann Surg Oncol; 2013 Sep; 20(9):2908-13. PubMed ID: 23612884
[TBL] [Abstract][Full Text] [Related]
6. Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer.
Suzuki T; Shimada H; Nanami T; Oshima Y; Yajima S; Ito M; Washizawa N; Kaneko H
Surg Today; 2016 Dec; 46(12):1394-1401. PubMed ID: 27160890
[TBL] [Abstract][Full Text] [Related]
7. Elevated fibrinogen plasma level is not an independent predictor of poor prognosis in a large cohort of Western patients undergoing surgery for colorectal cancer.
Pedrazzani C; Mantovani G; Salvagno GL; Baldiotti E; Ruzzenente A; Iacono C; Lippi G; Guglielmi A
World J Gastroenterol; 2016 Dec; 22(45):9994-10001. PubMed ID: 28018106
[TBL] [Abstract][Full Text] [Related]
8. Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy.
Ikezawa K; Kanai M; Ajiki T; Tsukamoto T; Toyokawa H; Terajima H; Furuyama H; Nagano H; Ikai I; Kuroda N; Awane M; Ochiai T; Takemura S; Miyamoto A; Kume M; Ogawa M; Takeda Y; Taira K; Ioka T
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):98-104. PubMed ID: 23798367
[TBL] [Abstract][Full Text] [Related]
9. A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC).
Ruzzenente A; Iacono C; Conci S; Bertuzzo F; Salvagno G; Ruzzenente O; Campagnaro T; Valdegamberi A; Pachera S; Bagante F; Guglielmi A
Surgery; 2014 Apr; 155(4):633-9. PubMed ID: 24468034
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer.
Ke X; Jin B; You W; Chen Y; Xu H; Zhao H; Lu X; Sang X; Zhong S; Yang H; Mao Y; Du S
BMC Cancer; 2021 Aug; 21(1):953. PubMed ID: 34433454
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Plasma Fibrinogen is Associated with Lymph Node Metastasis and Predicts Prognosis in Resectable Esophageal Cancer.
Wakatsuki K; Matsumoto S; Migita K; Ito M; Kunishige T; Nakade H; Nakatani M; Kitano M; Sho M
World J Surg; 2017 Aug; 41(8):2068-2077. PubMed ID: 28321554
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysis.
Tang H; Lu W; Li B; Li C; Xu Y; Dong J
Oncotarget; 2017 May; 8(22):36857-36868. PubMed ID: 28415734
[TBL] [Abstract][Full Text] [Related]
13. Hyperfibrinogen Is Associated With the Systemic Inflammatory Response and Predicts Poor Prognosis in Advanced Pancreatic Cancer.
Qi Q; Geng Y; Sun M; Chen H; Wang P; Chen Z
Pancreas; 2015 Aug; 44(6):977-82. PubMed ID: 25931258
[TBL] [Abstract][Full Text] [Related]
14. Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer.
Fornaro L; Cereda S; Aprile G; Di Girolamo S; Santini D; Silvestris N; Lonardi S; Leone F; Milella M; Vivaldi C; Belli C; Bergamo F; Lutrino SE; Filippi R; Russano M; Vaccaro V; Brunetti AE; Rotella V; Falcone A; Barbera MA; Corbelli J; Fasola G; Aglietta M; Zagonel V; Reni M; Vasile E; Brandi G
Br J Cancer; 2014 Apr; 110(9):2165-9. PubMed ID: 24714745
[TBL] [Abstract][Full Text] [Related]
15. Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study.
Shu YJ; Weng H; Bao RF; Wu XS; Ding Q; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Li ML; Mu JS; Wu WG; Liu YB
BMC Cancer; 2014 Aug; 14():566. PubMed ID: 25096189
[TBL] [Abstract][Full Text] [Related]
16. Real-life analysis of treatment approaches and the role of inflammatory markers on survival in patients with advanced biliary tract cancer.
Goktas Aydin S; Cakan Demirel B; Bilici A; Topcu A; Aykan MB; Kahraman S; Akbıyık I; Atci MM; Olmez OF; Yaren A; Sendur MAN; Geredeli C; Seker M; Urun Y; Karadurmus N; Aydin A
Curr Med Res Opin; 2022 Oct; 38(10):1751-1758. PubMed ID: 35916475
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: a large retrospective study.
Walter T; Horgan AM; McNamara M; McKeever L; Min T; Hedley D; Serra S; Krzyzanowska MK; Chen E; Mackay H; Feld R; Moore M; Knox JJ
Eur J Cancer; 2013 Jan; 49(2):329-35. PubMed ID: 22947649
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancreatico-biliary malignancies.
Spolverato G; Maqsood H; Kim Y; Margonis G; Luo T; Ejaz A; Pawlik TM
J Surg Oncol; 2015 Jun; 111(7):868-74. PubMed ID: 25865111
[TBL] [Abstract][Full Text] [Related]
19. Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations.
Neuzillet C; Casadei Gardini A; Brieau B; Vivaldi C; Smolenschi C; Brandi G; Tougeron D; Filippi R; Vienot A; Silvestris N; Pointet AL; Lonardi S; Rousseau B; Scartozzi M; Dahan L; Aprile G; Boussaha T; Malka D; Crusz SM; Le Sourd S; Meurisse A; Lièvre A; Vernerey D; ; ; ;
Eur J Cancer; 2019 Apr; 111():94-106. PubMed ID: 30826661
[TBL] [Abstract][Full Text] [Related]
20. Body mass index and weight change during initial period of chemotherapy affect survival outcome in advanced biliary tract cancer patients.
Kang J; Lee SH; Son JH; Lee JW; Choi YH; Choi JH; Paik WH; Ryu JK; Kim YT
PLoS One; 2018; 13(4):e0195118. PubMed ID: 29608578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
